Complementary replacement therapy for chronic gastritis

Author:

Mi Liu,Weiai Liu,Chang She,Jingying Zhou,Xuan Xu,Haolong He

Abstract

Gastritis, an inflammation of the stomach lining, arises from diverse causes and ranks among the most frequent digestive ailments. It typically falls into two categories based on the speed of onset: acute and chronic gastritis. Patients with acute gastritis are generally managed symptomatically. Meanwhile, those with chronic gastritis experience ongoing discomfort like epigastric pain, belching, and acid reflux, negatively impacting their quality of life. They can benefit from presently approved medical treatments. To alleviate the physical and mental burden of chronic gastritis and enhance life quality, many patients explore complementary and alternative therapies (CAM). A wide array of CAM options exists, but their safety and effectiveness remain uncertain. If supported by robust evidence, these therapies could potentially become part of standard medical practice for treating chronic gastritis. Approaches like Traditional Chinese Medicine, Acupuncture, Tuina, Diet, Exercise, and Psychological Interventions have demonstrated the capacity to ameliorate symptoms and enhance the well-being of chronic gastritis patients. Identifying high-quality evidence regarding efficacy and safety through Randomized Controlled Trials (RCTs) can facilitate the broader integration of CAM in chronic gastritis treatment. This section offers an overview of the most recent clinical trial findings concerning complementary and alternative therapies.

Publisher

IntechOpen

Reference55 articles.

1. Tian G, Wu C, Li J, et al. Network pharmacology based investigation into the effect and mechanism of modified Sijunzi decoction against the subtypes of chronic atrophic gastritis. Pharmacological Research. 2019;:158-166

2. Zhao YS. Clinical analysis of modified Banxia Xiexin decoction in the treatment of chronic atrophic gastritiswith cold-heat complicated syndrome. Chinese Journal of Modern Drug Application. 2023;(13):148-150

3. Ma CL, Xiao JC, Wang Y, et al. Clinical study of Moluodan combined with hydrotalcite in treatment of chronic atrophic gastritis. Drugs Clin. 2023;(07):1702-1706

4. Yu B, Huang LQ , Gao Y, et al. Dhase IV clinical trial of ligi Nuanwei granules in the treatment of chronic superficial gastritis. The Chinese Journal of Clinical Pharmacology. 2020;(22):3608-3611

5. Hu CP, Cai YS, Yang W, et al. Curative effect analysis of Pingwei decoction in the treatment of 60 cases of chronic gastritis atrophy and intestinal metaplasia. Journal of Sichuan Traditional Chinese Medicine. 2021;(05):102-104

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3